-
Information Leaflets for ICPerMed Working Groups
08 November 2021 – Interested in finding out more about the aims and activities of ICPerMed working groups? Information leaflets informing about the aims and activities of the groups are now available. The ICPerMed Working Groups consist of ICPerMed members and external experts and support ICPerMed activities. They work on topics prioritized by ICPerMed.
-
Personalised Medicine Workshop of the Paul-Ehrlich-Institute
27 October 2021 – The Paul-Ehrlich-Institute in Germany invites to a virtual workshop: “The Next Frontiers in Development and Clinical Application of Personalized Medicines” on November 15, 2021. The aim of the workshop is to present the current state of the art in personalized medicine and to explore the challenges in research and innovation to…
-
Pre-Announcement of the fifth ERA PerMed Call for Proposals
21 October 2021 – ERA-PerMed will launch its new call on “Prevention in Personalised Medicine” presumably on 01 December 2021. An open information day introducing the joint transnational call 2022 to the research community will be organised by ERA PerMed on December 9th, 2021. It is possible to start connecting with other research organisations already…
-
ICPerMed Training Event “Personalised Medicine Research: Key issues”
20 October 2021 – ICPerMed is happy to announce the 1st “ICPerMed Training – Personalised Medicine Research: Key issues” on 1-2 December 2021 (two half days). The target group of the training are actors (including researchers and practioners) worldwide at the very beginning of their careers, with a reliable interest in personalised medicine (PM). About…
-
XIIth ICPerMed Newsletter is online
27. September 2021 – ICPerMed published its XIIth Newsletter informing interested stakeholders about new developments, important events and research progress in the field of personalised medicine.
-
The “HAZLO” project: A personalised cardiac rehabilitation programme
Globally, cardiovascular diseases (CVDs) account for approximately 50% of deaths from non-communicable diseases (NCDs) and are attributed a 10% global disease burden (DALY). Cardiac rehabilitation programmes aim at contributing to the recovery and secondary prevention of cardiac events, promote healthy behaviour, increase understanding of the new health condition and improve the psychosocial well-being of the…
-
MedeA: Clinical Implementation of a Pharmacogenetics Personalised Prescription System based on e-health in a European Regional Health Service
The MedeA (Medicina Personalizada Aplicada, Applied Personalised Medicine) Initiative is a genuine personalized medicine (PM) clinical implementation programme. It is based on an analysis of each patient’s individual pharmacogenetic biomarkers, drug-drug interactions and clinical data evaluated in an e-health strategy. This information is fed into a software system called Personalized oriented Prescription System (PoPS). It…
-
EP PerMed Information Event – Presentations online
11 June 2021 – The virtual Information Event “European Partnership for Personalised Medicine (EP PerMed) calling for national and regional involvement” organised by ICPerMed and ERA PerMed took place on May 31, 2021.
-
Sino-EU PerMed Workshop
8 June 2021 – Sino-EU PerMed invites to a workshop about Cooperation between China and Europe in Personalised Medicine. The results of a Sino-EU scientific and technological mapping and present best-practice examples for Sino-EU Cooperation will be presented. The workshop will be held in English and Chinese.
-
EP PerMed Information Sheets
27 May 2021 – In follow up of the “guidance document”, seven Information Sheets (download below) were developed by the ICPerMed and ERA PerMed “Preparatory Group”, comprising of four representatives of each initiative. The Information Sheets aim to promote the preparations of the European Partnership for Personalised Medicine (EP PerMed), which has been proposed to…
